AI Summary: Dr. Tarek I. Hassanein is a board-certified transplant hepatologist and gastroenterologist who has practiced since 1983. As Medical Director of Southern California Liver Centers, he sees patients at nine offices across San Diego, Riverside, Orange and Los Angeles counties and treats fatty liver disease (MASLD and MASH), hepatitis B and C, cirrhosis, liver cancer and other liver conditions. He is accepting new patients, offers telehealth, speaks English, Spanish and Arabic, and accepts plans including Medicare, Medicaid and TRICARE.
Dr. Hassanein diagnoses and treats the full range of liver disease, from fatty liver disease and viral hepatitis to cirrhosis and liver cancer, and cares for patients before and after a liver transplant.
Dr. Tarek I. Hassanein is a transplant hepatologist and gastroenterologist who has cared for patients with liver disease since 1983. He is the Medical Director of Southern California Liver Centers, Director of the Southern California Research Center and a Professor of Medicine at the University of California, San Diego.
He earned his medical degree with honors and a master's degree in internal medicine at Alexandria University in Egypt, completed his internal medicine residency at Wayne State University in Detroit, and trained in gastroenterology and hepatology at the University of Pittsburgh. He is board certified in internal medicine, gastroenterology and transplant hepatology.
At UC San Diego he served as Medical Director of Liver Transplantation from 1997 to 2009 and as Transplant Hepatology Medical Director from 2014 to 2022. He also directed the Liver Clinical Trials Center, led the Specialized Liver Cancer Unit at Moores Cancer Center and was Chief of Clinical Hepatology. Elsewhere in San Diego he was Associate Director of Liver Transplantation at Scripps Green Hospital and Chief of Gastroenterology and Hepatology at Sharp Coronado Hospital.
Dr. Hassanein has been principal investigator on more than 310 clinical studies and has published more than 225 journal articles, including trials of hepatitis C cures in the New England Journal of Medicine and The Lancet and studies of new treatments for fatty liver disease. He sees patients in English, Spanish and Arabic.
Education
M.B., Ch.B. with honors, Alexandria University, Egypt (1982)
Master of Science in Internal Medicine, Alexandria University (1987)
Residency in Internal Medicine, Wayne State University, Detroit (1990–1992)
Fellowship in Gastroenterology and Hepatology, University of Pittsburgh (1992–1994)
Research Fellowship, University of Pittsburgh (1988–1990)
Certifications
American Board of Internal Medicine, Diplomate (1992)
American Board of Gastroenterology, Diplomate (1993)
Transplant Hepatology, American Board of Internal Medicine (2006)
California Medical License A54452
Fellowships
American Association for the Study of Liver Diseases (FAASLD)
American College of Gastroenterology (FACG)
American College of Physicians (FACP)
American Gastroenterological Association (AGAF)
Current Positions
Medical Director, Southern California Liver Centers (since 2009)
Director, Southern California Research Center (since 2009)
Professor of Medicine, University of California, San Diego (since 2009)
President, Southern California Transplantation Institute Research Foundation (since 1998)
Previous Positions
Transplant Hepatology Medical Director, UC San Diego (2014–2022)
Chief of Gastroenterology and Hepatology, Sharp Coronado Hospital (2009–2021)
Associate Director of Liver Transplantation, Scripps Green Hospital (2009–2014)
Medical Director of Liver Transplantation, UC San Diego (1997–2009)
Chief, Specialized Liver Cancer Unit, Moores Cancer Center, UC San Diego (2004–2009)
Director, Liver Clinical Trials Center, UC San Diego (1998–2010)
Chief of Hepatology and Transplant Gastroenterology, Loma Linda University (1995–1997)
Research
Principal investigator on more than 310 clinical studies
More than 225 journal publications
More than 365 presented and published abstracts
Philosophy of Care
“The patient is the center of our universe. Our doctors and staff work toward restoring liver health, and our philosophy is focused on the patient.”
Published work by Dr. Tarek I. Hassanein
Research & Publications
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
Alkhouri N, Herring R, Kabler H, … Hassanein T, et al. J Hepatol. 2022;77(3):607-618.
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
Roth D, Nelson DR, Bruchfeld A, … Hassanein T, et al. Lancet. 2015;386(10003):1537-45.
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
Here Aimy answers from what Dr. Hassanein’s practice has shared, like insurance, office hours and locations, and from our reviewed liver health information. She can’t book appointments or give medical advice: for those, contact the office.
Not sure what to do next
Get the information and support you need to move forward
Learn about your condition
Get easy-to-understand information about your condition, treatment options, and questions to ask your doctor.
Yes. Dr. Hassanein is accepting new patients. You can request an appointment on this page or call Southern California Liver Centers at (619) 522-0399.
Where does Dr. Hassanein see patients?
At nine Southern California Liver Centers offices: Coronado, Chula Vista (Eastlake), El Cajon, Escondido, San Clemente, Riverside, Garden Grove, Los Angeles (Century City) and Panorama City. Each office's address is listed under Locations.
Does Dr. Hassanein offer telehealth visits?
Yes, telehealth visits are available. Call the office to find out whether a virtual visit suits your situation.
Which insurance plans does Dr. Hassanein accept?
The office accepts Aetna, Blue Cross Blue Shield, Cigna, Humana, UnitedHealthcare, Medicare, Medicaid, Anthem (Elevance Health), Molina Healthcare, Ambetter, TRICARE and Health Care Service Corporation plans. Coverage varies by plan, so please confirm yours with the office before your visit.
What conditions does Dr. Hassanein treat?
Liver diseases including fatty liver disease (MASLD and MASH), hepatitis B and C, autoimmune hepatitis, fibrosis and cirrhosis, liver cancer, primary biliary cholangitis, primary sclerosing cholangitis, hemochromatosis, Wilson's disease, alcohol-associated liver disease, portal hypertension and drug-induced liver injury.
Does Dr. Hassanein perform liver transplant surgery?
No. As a transplant hepatologist, Dr. Hassanein evaluates patients for a liver transplant and cares for them before and after the operation, which is performed by a transplant surgeon.
What languages does Dr. Hassanein speak?
English, Spanish and Arabic.
What are the office hours?
The Coronado office is open from 8:00 AM to 5:00 PM. Please call (619) 522-0399 to confirm the hours of the office you plan to visit.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.